Drug Profile
Research programme: hepatitis C virus protein inhibitors - TaiGen
Alternative Names: HCV polymerase NS5B inhibitors - TaiGen; HCV protease inhibitors - TaiGenLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator TaiGen Biotechnology
- Class
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-C in Taiwan